Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05419)

• Formulation Name: Desvenlafaxine 50 mg tablet
• Company: Sun Pharmaceutical Industries

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Desvenlafaxine	(DMHD4PE)	Major depressive disorder	6A70.3	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Citric acid monohydrate	(E00271)	22230	Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
Eisenoxyd	(E00585)	56841934	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 6000	(E00655)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Vinylpyrrolidone	(E00668)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent